Comparative clinical study to evaluate the efficacy of Shigru Kwatha and Gokshura Churna in the management of Essential Hypertension- Randomized Control Study

Ayurvedic and Unani Tibbia College and Hospital0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Subjects willing to participate and able to provide written informed consent.
•2. Subjects belonging to either gender between the age group 20 to 60 years.
•3. Patient diagnosed as Stage- 1 E.H.T. would be selected for study on the basis of 7th JNC & WHO criteria.
•4. Subjects who are able to come for follow up on fixed visits and are well aware about the treatment plan.

•1. Already diagnosed cases of Cardiovascular disease/ Cerebrovascular disease / Renal disease/ Hypertensive Retinopathy.
•2. Subjects with any unstable Heart disease or known cases of MI, unstable angina or CHF.
•3. Patients with concurrent Hepatic Dysfunction (defined as AST and/or ALT > 2 times of the upper normal limit) or Renal Dysfunction, uncontrolled Pulmonary Dysfunction (asthmatic and COPD subjects).
•4. Subjects with current or past diagnosis of malignancy (any malignancy diagnosis in last five years).
•5. Subjects who have a recent history or who are currently known to abuse of alcohol or drugs.
•6. Subjects suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, TB, AIDS etc).
•7. Female subject of child bearing potential who do not agree to remain abstinent or use medically acceptable methods of contraception during the study therapy and for 4 weeks after the end of study therapy.
•8. Pregnant / Lactating women.
•9. Subject on systemic or oral steroids, oral contraceptive pills or estrogen replacement therapy.
•10. Subjects having hypersensitivity to any of the trial drug.
•11. Subjects who have completed participation in any other clinical trial during the past six (06) months.
•12. Pregnancy induced hypertension.

发起方

Ayurvedic and Unani Tibbia College and Hospital